Looks like you’re on the UK site. Choose another location to see content specific to your location
Smith and Nephew study shows further benefits of Pico wound management
Smith and Nephew has announced the publication of new clinical trial data showing the benefits offered by its single-use negative pressure wound therapy system Pico.
A randomised controlled trial of 220 patients undergoing primary hip or knee replacement at the Robert Jones and Agnes Hunt Orthopaedic Hospital in Shropshire compared the use of Pico with standard dressings on closed surgical incisions over a 12-month period.
The results showed that Pico was associated with significant reductions in wound exudate distribution within the dressing, the number of dressing changes and the length of stay in hospital among those patients.
This can help to mitigate the financial impact on the family – as less time off work is required by the patient and carer – as well as offering benefits for hospitals and service providers.
Sudheer Karlakki, lead study author and consultant orthopaedic surgeon at the Robert Jones and Agnes Hunt Orthopaedic Hospital, said: "Better wound management offers significant value to our hospital both in terms of reducing associated healthcare costs and by improving each patient’s outcome and experience."
The company recently held a meeting in Paris at which more than 160 European experts in plastic and oncoplastic surgery praised the Pico system for its effectiveness in reducing postoperative wound complications.
With over 20 years of experience within the medical devices market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current medical device roles we have available, you can search for the latest job roles, register your details, or contact the team today.
We have hundreds of jobs available across the Healthcare industry, find your perfect one now.
Stay informed
Receive the latest industry news, Tips and straight to your inbox.
- Share Article
- Share on Twitter
- Share on Facebook
- Share on LinkedIn
- Copy link Copied to clipboard